CRYSTAL RILEY: Open Payments
NPI 1578957585 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 11 payments from 10 companies in 2025. Trend: 2023 $106 · 2024 $189 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $49 |
| Amgen Inc. | 1 | $31 |
| PFIZER INC. | 1 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $30 |
| ARGENX US, INC. | 1 | $26 |
| Biogen, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| GENZYME CORPORATION | 1 | $17 |
Products named: UPLIZNA, BOTOX, NURTEC ODT, CREXONT, VYVGART HYTRULO, VUMERITY, AMYVID, KESIMPTA.
Industry payments across MD — which companies pay providers there.
